Immune Checkpoint Inhibitors

AI Model MSI-SEER Validated Across Diverse Cancer Cohorts and Prepares for Prospective Trials

Its Monte Carlo dropout–based confidence scoring enables a reliable AI–human collaboration for scalable MSI testing.